Lymphatic vessel density in the neoplastic progression of Barrett's oesophagus to adenocarcinoma

Journal of Clinical Pathology

Volumn 59, Issue 2, 2006, Pages 191-195

  Brundler, M A ^b,c   Harrison, J A ^b   De Saussure, B ^b   De Perrot, M ^b   Pepper, M S ^a,b  

^a Netcare Unitas Hospital   (South Africa)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^c BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER RISK; CANCER TISSUE; CONTROLLED STUDY; DYSPLASIA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPH VESSEL; MAJOR CLINICAL STUDY; MALE; METAPLASIA; MICROVASCULARIZATION; PRIORITY JOURNAL; PROGNOSIS; STOMACH; SURVIVAL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MALE; METAPLASIA; MIDDLE AGED; NEOPLASM STAGING; PRECANCEROUS CONDITIONS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 32544432129     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2005.028118     Document Type: Article

References (29)

1. Pera M. Trends in incidence and prevalence of specialized intestinal metaplasia, Barrett's esophagus, and adenocarcinoma of the gastroesophageal junction. World J Surg 2003;27:999-1008.
2. Sampliner RE. Adenocarcinoma of the esophagus and gastric cardia: is there progress in the face of increasing cancer incidence? Ann Intern Med 1999;130:67-9.
3. Spechler SJ. Clinical practice. Barrett's esophagus. N Engl J Med 2002;346:836-42.
4. Corey KE, Schmitz SM, Shaheen NJ. Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis. Am J Gastroenterol 2003;98:2390-4.
5. Hawk E. Report of the stomach/esophageal cancers progress review group. National Cancer Institute, 2002 (http://searchosp1. nci.nih.gov/stomach/ stomach_esophageal.pdf).
6. Boyce HW. Barrett esophagus: endoscopic findings and what to biopsy. J Clin Gastroenterol 2003;36:S6-18.
7. Reid BJ, Blount PL, Rabinovitch PS. Biomarkers in Barrett's esophagus. Gastrointest Endosc Clin N Am 2003;13:369-97.
8. Mandriota SJ, Jussila L, Jeltsch M, et al. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 2001;20:672-82.
9. Banerji S, Ni J, Wang SX, et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 1999;144:789-801.
10. Hermanek P, Hutter RVP, Sobin LH, et al, eds. TNM atlas. Illustrated guide to the TNM/pTNM classification of malignant tumours. Berlin: Springer-Verlag, 1997.
11. Nisato RE, Harrison JA, Buser R, et al. Generation and characterization of telomerase-transfected human lymphatic endothelial cells with an extended life span. Am J Pathol 2004;165:11-24.
12. Clarijs R, Schalkwijk L, Hofmann UB, et al. Induction of vascular endothelial growth factor receptor-3 expression on tumor microvasculature as a new progression marker in human cutaneous melanoma. Cancer Res 2002;62:7059-65.
13. Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992;84:1875-87.
14. Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
15. Hall NR, Fish DE, Hunt N, et al. Is the relationship between angiogenesis and metastasis in breast cancer real? Surg Oncol 1992;1:223-9.
16. Bosari S, Lee AK, DeLellis RA, et al. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 1992;23:755-61.
17. Vermeulen PB, Gasparini G, Fox SB, et al. Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer 1996;32A:2474-84.
18. Leu AJ, Berk DA, Lymboussaki A, et al. Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. Cancer Res 2000;60:4324-7.
19. Padera TP, Kadambi A, di Tomaso E, et al. Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 2002;296:1883-6.
20. Auvinen MI, Sihvo EI, Ruohtula T, et al. Incipient angiogenesis in Barrett's epithelium and lymphangiogenesis in Barrett's adenocarcinoma. J Clin Oncol 2002;20:2971-9.
21. Clarijs R, Schalkwijk L, Hofmann UB, et al. Induction of vascular endothelial growth factor receptor-3 expression on tumor microvasculature as a new progression marker in human cutaneous melanoma. Cancer Res 2002;62:7059-65.
22. Straume O, Jackson DG, Akslen LA. Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma. Clin Cancer Res 2003;9:250-6.
23. Valencak J, Heere-Ress E, Kopp T, et al. Selective immunohistochemical staining shows significant prognostic influence of lymphatic and blood vessels in patients with malignant melanoma. Eur J Cancer 2004;40:358-64.
24. Straume O, Akslen LA. Lymphatic vessel density and prognosis in cutaneous melanoma. Br J Cancer 2004;91:1224-5.
25. Maula SM, Luukkaa M, Grenman R, et al. Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region. Cancer Res 2003;63:1920-6.
26. Padera TP, Boucher Y, Jain RK. Correspondence re: S. Maula, et al. Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinoma of the head and neck. Cancer Res 2003;63:8555-6.
27. Couvelard A, Paraf F, Gratio V, et al. Angiogenesis in the neoplastic sequence of Barrett's oesophagus. Correlation with VEGF expression. J Pathol 2000;192:14-18.
28. Torres C, Wang H, Turner J, et al. Prognostic significance and effect of chemoradiotherapy on microvessel density (angiogenesis) in esophageal Barrett's esophagus-associated adenocarcinoma and squamous cell carcinoma. Hum Pathol 1999;30:753-8.
29. Lord RV, Park JM, Wickramasinghe K, et al. Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus. J Thorac Cardiovasc Surg 2003;125:246-53.